Answer
Thrombosis was the most serious adverse drug reaction reported with marstacimab in clinical studies, occurring in 0.9% of patients.
Sources for this answer
- Hympavzi 150 mg solution for injection in pre-filled penPfizer Limited · emc · SmPC §4.8 Undesirable effects · Version 4Document updated
Sources checked